Kevin is a Managing Director in the Investment Banking Division who joined CG through the Results IG acquisition. He has over 35 years’ experience working in the healthcare sector, principally with pharmaceutical, biotechnology, business consultancy and advisory companies. He has been involved in the successful transaction of many businesses around the globe, acting as advisor to investors, major pharmaceutical, biotechnology, as well as founder-owned and PE-backed, healthcare companies.
During his career Kevin has held senior positions in life science and advisory companies. He has worked at Sanofi (Hoechst), IQVIA (Quintiles), Roche Pharmaceuticals, Inpharmatica, PharmaVentures & Results Healthcare.
View Kevin's LinkedIn
Selected Transactions
-
UCB
Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma
-
Noramco
Financial Advisor (Sell side)
-
N/a
Novartis
Financial Adviser (Sell side)
-
N/a
Recipharm
Financial Adviser (Sell side)
-
N/a
InvoX
Financial Adviser (Buy side)
-
N/a
Orphan Reach
Financial Adviser (Sell side)
-
N/a
Novartis
Exclusive Financial Adviser (Sell side)
-
£110m
Sino Biopharmaceutical
Financial Advisor (Buy side)
-
N/a
MSD
Exclusive Financial Advisor (Sell side)
